SCHEMBL335114

SCHEMBL335114

C=NC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8591102 0.74
SCHEMBL16404820 0.70
SCHEMBL23230924 0.70
SCHEMBL20529112 0.65
SCHEMBL21335958 0.62
SCHEMBL24500923 0.62
SCHEMBL4062894 0.60
SCHEMBL13199461 0.59
SCHEMBL35543 0.59
SCHEMBL35542 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109331875-A A kind of double-core magnesium metallic catalyst and its preparation method and application 山西大学 2019-02-15 CN claimed
EP-2629608-B1 PROTECTED ANTIMICROBIAL COMPOUNDS FOR HIGH TEMPERATURE APPLICATIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2016-07-13 EP claimed
US-7569719-B1 Method of preparing electron deficient olefins LOCTITE (R&D) LIMITED (IE) 2009-08-04 US claimed
EP-0700399-B1 36-DERIVATIVES OF RIFAMYCINS AND THEIR USE AS ANTIMICROBIAL AGENTS LEPETIT SPA (IT) 2001-10-04 EP claimed
US-5786350-A CONDENSATION; HYDROLYSIS; DEPROTECTING GRUPPO LEPETIT S.P.A. (IT) 1998-07-28 US claimed
EP-0700399-A1 36-DERIVATIVES OF RIFAMYCINS AND THEIR USE AS ANTIMICROBIAL AGENTS GRUPPO LEPETIT S.P.A. (IT) 1996-03-13 EP claimed
WO-1994028002-A1 36-DERIVATIVES OF RIFAMYCINS AND THEIR USE AS ANTIMICROBIAL AGENTS GRUPPO LEPETIT S.P.A. (IT) 1994-12-08 WO claimed
US-11912723-B2 KRAS modulators and uses thereof QUANTA THERAPEUTICS, INC. (US) 2024-02-27 US disclosed
US-20230374042-A1 KRAS MODULATORS AND USES THEREOF QUANTA THERAPEUTICS, INC. 2023-11-23 US disclosed
US-20230365563-A1 QUINAZOLINE COMPOUND AND APPLICATION THEREOF SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2023-11-16 US disclosed
US-20230242699-A1 POLYCARBAMATE SYNTHESIS VIA CHAIN-GROWTH COPOLYMERIZATION FENG, Xiaoshuang (CN) 2023-08-03 US disclosed
US-10759754-B2 Aminobenzoic acid derivatives for use as anti-inflammatory agents, anti-metastatic agents and/or anticancer agents 3R VALO, S.E.C. (CA) 2020-09-01 US disclosed
US-20190127325-A1 AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS UNIVERSITÉ DU QUÉBEC À TROIS-RIVIÈRES (CA) 2019-05-02 US disclosed
US-4399268-A POLYEPOXIDE, SUBSTITUTED AMINOPHENOL HOECHST AKTIENGESELLSCHAFT (DE) 1983-08-16 US disclosed
US-4368162-A Process for producing aminomethylphosphonic acid CIBA-GEIGY CORPORATION (US) 1983-01-11 US disclosed
EP-0068263-A1 Use of Mannich bases for the production of moulded articles, Mannich bases and process for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1983-01-05 EP disclosed
US-4357476-A Nonylamines CIBA GEIGY CORPORATION, N.Y. (US) 1982-11-02 US disclosed
EP-0042617-A1 Process for the production of shaped articles and coatings HOECHST AKTIENGESELLSCHAFT (DE) 1981-12-30 EP disclosed
US-4189409-A LIGHT STABILIZERS, IN THE PRESENCE OF AN ACID CATALYST ARGUS CHEMICAL CORPORATION (US) 1980-02-19 US disclosed
US-4139560-A Nonylamines CIBA GEIGY CORPORATION (US) 1979-02-13 US disclosed